Analystreport

Voyager Therapeutics (NASDAQ: VYGR) was given a new $35.00 price target on by analysts at Canaccord Genuity. They now have a "buy" rating on the stock.

Voyager Therapeutics, Inc.  (VYGR) 
Last voyager therapeutics, inc. earnings: 3/3 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.voyagertherapeutics.com